Trial · NCT07909421
A Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies
NCT07909421, Not applicable, Not yet recruiting, Galderma R&D
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies. Trials, record NCT07909421. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909421
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies
- NCT number
- NCT07909421
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 326 participants, estimated
- Lead sponsor
- Galderma R&D
- Conditions
- Cheek Wrinkles, Midface Contour Deficiencies
- Interventions
- GP0112, Juvéderm Voluma XC
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Responder rate based on the Blinded Evaluators' live assessment using the Medicis Midface Volume Scale (MMVS). | At Month 6 after last treatment. | A responder is defined as a subject with at least 1 grade improvement from baseline on both sides of the face concurrently. |
| Secondary | Responder rate based on the Blinded Evaluator's live assessment of the MMVS. | At Months 1, 3, 9 and 12 after last treatment. | |
| Other | Change from baseline in subject satisfaction using the FACE-Q Natural Appearance questionnaires Rasch transformed total scores as well as proportion of subjects in each response category for each of the individual questions. | At Months 1, 3, 6, 9 and 12 after last treatment. | |
| Other | Change from baseline in subject satisfaction using the FACE-Q Natural Outcome questionnaires Rasch transformed total scores as well as proportion of subjects in each response category for each of the individual questions. | At Months 1, 3, 6, 9 and 12 after last treatment. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909421
GET https://conductscience.org/api/trials/v1/NCT07909421/registered